NICE IDs

11/07/2025

ID3981: Isatuximab in combination for untreated multiple myeloma when a stem cell transplant is unsuitable

04/07/2025

ID6372: Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people aged 6 years and over

25/06/2025

ID6274: Fruquintinib for previously treated metastatic colorectal cancer

20/06/2025

ID6392: Zanubrutinib for treating relapsed or refractory mantle cell lymphoma after 1 or more treatments

19/06/2025

ID6153: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive, HER2-negative early breast cancer

06/06/2025

ID6221: Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over

03/06/2025

ID6411: Dapagliflozin for treating chronic kidney disease

27/05/2025

ID6244: Mirikizumab for treating moderately to severely active Crohn's disease

23/05/2025

ID3949: Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer

21/05/2025

ID6222: Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease

20/05/2025

ID6317: Durvalumab with platinum-based chemotherapy, then with or without olaparib, for treating newly diagnosed advanced or recurrent endometrial cancer [ID6317]

01/05/2025

ID6308: Sparsentan for treating primary IgA nephropathy

25/04/2025

ID6357: Linzagolix for treating symptoms of endometriosis

02/04/2025

ID6328: Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer

25/03/2025

ID1136: Nivolumab with ipilimumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency

13/03/2025

ID6340: Molnupiravir for treating COVID-19

12/03/2025

ID6263: Cladribine for treating relapsing multiple sclerosis

06/03/2025

ID6130: Leniolisib for activated phosphoinositide 3-kinase delta syndrome in people 12 years and over

20/02/2025

ID6170: Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A

17/02/2025

ID5123: Zolbetuximab with chemotherapy for untreated claudin 18.2-positive HER2 negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma